Statine-derived tetrapeptide inhibitors of β-secretase

Bibliography

• SISODIA SS: Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sd. USA(1992) 89:6075–6079.
   PubMed Web of Science ®Google Scholar
• MCCONLOGUE LC, AGARD DA, OTA N, TATSUNO G: Functional analysis of 13-secretase using mutagenesis and structural homology modeling. Neurobiol. Aging(2000) 21\(Supp1.1):S278 (Abstract 1272).
   Google Scholar
• CITRON M, WESTAWAY D, XIA W etal.:Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloidp-protein in both transfected cells and transgenic mice. Nat. Med.(1997) 3:67–72.
   Google Scholar
• HARDY J, ALLSOP D: Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. (1991) 12:383–388.
   PubMed Web of Science ®Google Scholar
• JARRETT JT, BERGER EP, LANSBURY PT, JR.: The carboxy terminus of the 13 amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry(1993) 32:4693–4697.
   Google Scholar
• SUZUKI N, CHEUNG T, CAI XD et al.:An increased percentage of long amyloidp-protein secreted by familial amyloid 13-protein precursor (APP717) mutants. Science(1994) 264:1336–1340.
   PubMed Web of Science ®Google Scholar
• CITRON M, DIEHL TS, GORDON G et al.:Evidence that the 42- and 40-amino acid forms of amyloid 13 protein are generated from the I3-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sri. USA(1996) 93:13170–13175.
   PubMed Web of Science ®Google Scholar
• KLAFKI H-W, ABRAMOWSKI D, SWOBODA R, PAGANETTI PA, STAUFENBIEL M: The carboxy termini of I3-amyloid peptides 1-40 and 1-42 are generated by distinct y-secretases. _J. Biol. Chem.(1996) 271:28655–28659.
   PubMedGoogle Scholar
• DE STROOPER B, SAFTIG P, GAESSAERTS K et al.:Deficiency of presenilin- 1 inhibits the normal cleavage of amyloid precursor protein. Nature(1998) 391:387–390.
   PubMed Web of Science ®Google Scholar
• SKOVRONSKY DM, LEE VM-Y: 13- secretase revealed: starting gate for race to novel therapies for Alzheimer's disease. Trends Pharmacol. Sci.(2000) 21:161–163.
   PubMedGoogle Scholar
• VASSAR R, BENNETT BD, BABU-KHAN S eta].:I3-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science(1999) 286:735–741.
   Google Scholar
• SINHA S, ANDERSON JP, BARBOUR R et al.:Purification and cloning of amyloid precursor protein I3-secretase from human brain. Nature(1999) 402:537–540.
   PubMed Web of Science ®Google Scholar
• YAN R, BIENKOWSKI MJ, SHUCK ME et al.:Membrane-anchored aspartyl protease with Alzheimer's disease I3-secretase activity. Nature(1999) 402:533–537.
   PubMed Web of Science ®Google Scholar
• HUSSAIN I, POWELL D, HOWLETT DR et al.:Identification of a novel aspartic protease (Asp 2) as I3-secretase. Ma. Cell Neurosci.(1999) 14:419–427.
   PubMed Web of Science ®Google Scholar
• FARZAN M, SCHNITZLER CE, VASILIEVA N, LEUNG D, CHOE H: BACE2, a I3-secretase homolog, cleaves at the I3-site and within the amyloid-I3 region of the amyloid 13 precursor protein. Proc. Nati Acad. Sri. USA(2000) 97:9712–9717.
   PubMed Web of Science ®Google Scholar
• SOLANS A, ESTIVILL X, DE LA LUNA S: A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein I3-secretase. Cytogerret. Cell Genet.(2000) 89:177–184.
   Google Scholar
• BENNETT BD, BABU-KHAN S, LOELOFF R et al.:Expression analysis of BACE2 in brain and peripheral tissues. Biol. Chem.(2000) 275:20647–20651.
   Web of Science ®Google Scholar
• ESPINOZA DO, POTEMPSKA A, MERZ G etal.:Roles of I3-amyloid converting enzymes BACE-1 and BACE-2 in I3-amyloid secretion. Neurobiol. Aging(2000) 21 (Supp1.1):S254 (Abstract 1 1 63).
   Google Scholar
• HANIU M, DENIS P, YOUNG Y et al.:Characterization of Alzheimer's I3-secretase protein BACE. A pepsin family member with unusual properties. j Biol. Chem.(2000) 275:21099–21106.
   Google Scholar
• LARNER AJ, ROSSOR MN: Alzheimer's disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid I3-peptides. Expert Opin. Ther. Patents(1997) 7:1115–1127.
   Web of Science ®Google Scholar
• GAMES D, ADAMS D, ALESSANDRINI R etal.:Alzheimer-type neuropathology in transgenic mice overexpressing V717F13-amyloid precursor protein. Nature(1995) 373:523–527.
   Google Scholar
• HSIAO K, CHAPMAN P, NILSEN S et al.:Correlative memory deficits, A13 elevation and amyloid plaques in transgenic mice. Science(1996) 274: 99–102.
   PubMed Web of Science ®Google Scholar
• SKOVRONSKY DM, MOORE DB, MILLA ME, DOMS RW, LEE VM-Y: Protein kinase C-dependent a-secretase competes with I3-secretase for cleavage of amyloid-I3 precursor protein in the trans-golgi network. j Biol. Chem.(2000) 275:2568–2575.
   PubMed Web of Science ®Google Scholar
• LAHIRI DK, GLASKY MS, FARLOW MR: Increased secretion of the I3-amyloid precursor protein in PC12 cells treated with a memory-enhancing drug AIT-082. Neurobiol. Aging(2000) 21 (Suppl. 1):S274 (abstract 1253).
   Google Scholar
• LARNER AJ: Hypothesis: amyloid 13-peptides truncated at the N-terminus Expert Op/n. Ther. Patents (2001)11(6)1049contribute to the pathogenesis of Alzheimer's disease. Neurobiol. Aging(1999) 20:65–69.
   Google Scholar
• LARNER AJ: N-terminal truncated amyloid I3-peptides and Alzheimer's disease. Neurobia Aging(2001) 22:In press.
   Google Scholar
• RUSSO C, SCHETTINI G, SAIDO TC et al.:Presenilin-1 mutations in Alzheimer's disease. Nature(2000) 405:531–532.
   PubMedGoogle Scholar
• SARGOVI HU, BURGESS K: Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agents. Expert Opin. Ther. Patents (1999)9:737–751.
   Google Scholar
• SOTO C, KASCSAK RJ, SABORIO GP et al.:Reversion of prion protein conformational changes by synthetic 13-sheet breaker peptides. Lancet(2000) 355:192–197.
   PubMed Web of Science ®Google Scholar
• LARNER AJ: Neuronal apoptosis as a therapeutic target in neurodegenerative disease. Expert Opin. Ther. Patents(2000) 10:1493–1518.
   Web of Science ®Google Scholar
• ABBENANTE G, KOVACS DM, LEUNG DL, CRAIK DJ, TANZI RE, FAIRLIE DP: Inhibitors of P-amyloid formation based on the I3-secretase cleavage site. Biochem. Biophys. Res. Commun.(2000) 268:133–135.
   PubMed Web of Science ®Google Scholar